Literature DB >> 1647211

The 5' untranslated region of encephalomyocarditis virus contains a sequence for very efficient binding of eukaryotic initiation factor eIF-2/2B.

G C Scheper1, A A Thomas, H O Voorma.   

Abstract

The mechanism by which internal ribosomal binding on the picornaviral RNA takes place is still not known. An important role has been suggested for eukaryotic initiation factors eIF-4A, eIF-4B, as well as for some not yet defined trans-acting factors like p52 for poliovirus and p58 for encephalomyocarditis virus (EMCV). In this paper we describe the competition between the 5' untranslated region (UTR) of EMCV and globin mRNA for the translational apparatus in rabbit reticulocyte lysates and show that the factor that is competed for is eIF-2/2B. The EMC 5' UTR is a very strong inhibitor of globin synthesis in the rabbit reticulocyte lysate because of a 30-fold higher eIF-2/2B binding capacity. Mutations 100 to 140 nucleotides upstream of the initiation codon led to a decreased efficiency to initiate translation and to a decreased ability to inhibit globin mRNA translation. The results suggest an important role for eIF-2/2B binding in EMC RNA translation and therefore in internal initiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647211     DOI: 10.1016/0167-4781(91)90011-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Novel fluorescence-based screen to identify small synthetic internal ribosome entry site elements.

Authors:  A Venkatesan; A Dasgupta
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  RNA-protein interactions in regulation of picornavirus RNA translation.

Authors:  G J Belsham; N Sonenberg
Journal:  Microbiol Rev       Date:  1996-09

3.  Revertant analysis of J-K mutations in the encephalomyocarditis virus internal ribosomal entry site detects an altered leader protein.

Authors:  M A Hoffman; A C Palmenberg
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.

Authors:  Y Ben-Asouli; Y Banai; H Hauser; R Kaempfer
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

5.  Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.

Authors:  M Kruger; C Beger; Q X Li; P J Welch; R Tritz; M Leavitt; J R Barber; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Conserved tertiary structural elements in the 5' nontranslated region of cardiovirus, aphthovirus and hepatitis A virus RNAs.

Authors:  S Y Le; J H Chen; N Sonenberg; J V Maizel
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

7.  Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro.

Authors:  Y V Svitkin; K Meerovitch; H S Lee; J N Dholakia; D J Kenan; V I Agol; N Sonenberg
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein.

Authors:  C U Hellen; G W Witherell; M Schmid; S H Shin; T V Pestova; A Gil; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Proteins binding to the leader of the 6.0 kb mRNA of human insulin-like growth factor 2 influence translation.

Authors:  C H de Moor; M Jansen; E J Bonte; A A Thomas; J S Sussenbach; J L Van Den Brande
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

10.  RNA--protein interactions within the internal translation initiation region of encephalomyocarditis virus RNA.

Authors:  A V Borovjagin; M V Ezrokhi; V M Rostapshov; T F Bystrova; I N Shatsky
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.